The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study
Castellano C, Sun T, Ravindranathan D, Hwang C, Balanchivadze N, Singh S, Griffiths E, Puzanov I, Ruiz‐Garcia E, Vilar‐Compte D, Cárdenas‐Delgado A, McKay R, Nonato T, Ajmera A, Yu P, Nadkarni R, O’Connor T, Berg S, Ma K, Farmakiotis D, Vieira K, Arvanitis P, Saliby R, Labaki C, Zarif T, Wise‐Draper T, Zamulko O, Li N, Bodin B, Accordino M, Ingham M, Joshi M, Polimera H, Fecher L, Friese C, Yoon J, Mavromatis B, Brown J, Russell K, Nanchal R, Singh H, Tachiki L, Moria F, Nagaraj G, Cortez K, Abbasi S, Wulff‐Burchfield E, Puc M, Weissmann L, Bhatt P, Mariano M, Mishra S, Halabi S, Beeghly A, Warner J, French B, Bilen M, Consortium F. The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study. Cancer 2024, 130: 2191-2204. PMID: 38376917, PMCID: PMC11141719, DOI: 10.1002/cncr.35247.Peer-Reviewed Original ResearchConceptsSupplemental O<sub>2</sub>COVID-19 severityMetastatic cancerLogistic regression modelsMetastases to other sitesSite of metastatic cancerCOVID-19 outcomesMetastasis to boneRetrospective cohort studyAll-Cause MortalityIntensive care unitDay mortalityLymph nodesIncreased hospitalization ratesMechanical ventilationCohort studyMetastasisCare unitPatientsCancer metastasisRegression modelsCancerSevere outcomesCancer ConsortiumOrdinal logistic regression model
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply